Skip to main content

Biological Interventions in Psychoses of Childhood

  • Chapter
Psychopathology and Child Development

Abstract

An up-to-date review of biological interventions in psychoses of childhood is presented here, together with occasional comments on efficacy based on the author’s experience. After brief mention of earlier forms of biological-organic treatment (psychosurgery, insulin, and electroconvulsive therapies), the review focuses on drug therapy. Relative prominence is given to major tranquilizers, lithium, and the hormones. Suitable information is also presented on hypnotics, anticonvulsants, sedatives, stimulants, antidepressant drugs, minor tranquilizers, hallucinogens, L-dopa, and vitamins. It is suggested that no specific drug is available for the treatment of any diagnostic category. Currently available drugs are most effective in reducing such symptoms as insomnia, hyperactivity, impulsivity, irritability, disorganized behavior, psychotic thought disorder, and certain types of aggressivity. The need for uniformity in the classification of child psychoses is stressed in light of its potential value in predicting responses of children to specific drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ajuriaguerra, J. de. Manuel de Psychiatrie de l’Enfant. Paris: Masson et Cie, 1971.

    Google Scholar 

  • Anderson, W.M., and Dawson, J. The variability of plasma 17-hydroxycorticosteroid levels in affective illness and schizophrenia. Psychosomatic Research, 1965, 9, 237–248.

    Article  Google Scholar 

  • Angrist, B., Sathananthan, G., and Gershon, S. Behavioral effects of L-dopa in schizophrenic patients. Psychopharmacologia, 1973, 31, 1–12.

    Article  PubMed  Google Scholar 

  • Annell, A. Insulin shock treatment in children with psychotic disturbances. Acta Psychotherapeutica Psychoanalytica Orthopoedica, 1955, 3, 193–205.

    Article  Google Scholar 

  • Annell, A. L. Manic-depressive illness in children and effect of treatment with lithium carbonate. Acta Paedopsychiatrica, 1969, 36, 292–361. (a).

    PubMed  Google Scholar 

  • Annell, A. L. Lithium in the treatment of children and adolescents. Acta Psychiatrica Scandinavica, 1969, 207 (Supp.), 19–30. (b).

    Article  Google Scholar 

  • Anton-Tay, F., and Wurtman, R. J. Brain monoamines and endocrine function. In L. Martini and W. F. Ganong (Eds.), Frontiers in neuroendocrinology. London: Oxford University Press, 1971.

    Google Scholar 

  • Arbit, J., Boshes, B., and Blonsky, R. Behavior and mentation changes during therapy. In A. Barbeau and F. H. McDowell (Eds.), L-dopa and Parkinsonism. Philadephia: Davis, 1970.

    Google Scholar 

  • Arnold, L. E., Kirilcuk, V., Corson, S. A., and Corson, E. O’L. Levoamphetamine and dextroamphetamine: Differential effect on aggression and hyperkinesis in children and dogs. American Journal of Psychiatry, 1973, 130, 165–170.

    PubMed  Google Scholar 

  • Arnold, L. E., and Wender, P. H. Levoamphetamine’s changing place in the treatment of children with behavior disorders. Pediatrics, 1975.

    Google Scholar 

  • Arnold, L. E., Wender, P. W., McCloskey, K., and Snyder, S. H. Levoamphetamine and dextroamphetamine: Comparative efficacy in the hyperkinetic syndrome. Archives of General Psychiatry, 1972, 27, 816–822.

    Article  PubMed  Google Scholar 

  • Balázs, R., Kovács, S., Cocks, W. A., Johnson, A. L., and Eayrs, J. T. Effect of thyroid hormone on the biochemical maturation of rat brain: Postnatal cell formation. Brain Research, 1971, 25, 555–570.

    Article  PubMed  Google Scholar 

  • Ban, T. A. Nicotinic acid in psychiatry. Canadian Psychiatric Association Journal, 1971, 16, 413–431.

    PubMed  Google Scholar 

  • Ban, T. A., and Lehman, H. E. Nicotinic acid in the treatment of schizophrenias. Progress Report I. Toronto: Canadian Mental Health Association, 1970.

    Google Scholar 

  • Bender, L. One hundred cases of childhood schizophrenia treated with electric shock. Transactions of the American Neurological Association, 1947, 72, 165–169.

    Google Scholar 

  • Bender, L. Theory, and treatment of childhood schizophrenia. Acta Paedopsychiatrica, 1967, 34, 298–307.

    Google Scholar 

  • Bender, L. The life course of children with schizophrenia. American Journal of Psychiatry. 1973, 130, 783–786.

    PubMed  Google Scholar 

  • Bender, L., Cobrinik, L., Faretra, G., and Sankar, D. V. S. The treatment of childhood schizophrenia with LSD and UML. In M. Rinkel (Ed.), Biological treatment of mental illness, New York: L. C. Page & Co., 1966.

    Google Scholar 

  • Bender, L., and Cottington, F. The use of amphetamine sulfate (Benzedrine) in child psychiatry. American Journal of Psychiatry, 1942, 99, 116–121.

    Google Scholar 

  • Bender, L., Goldschmidt, L., and Sankar, D. V. S. Treatment of autistic schizophrenic children with LSD-25 and UML-491. In J. Wortis (Ed.), Recent advances in biological psychiatry. New York: Plenum Press, 1962.

    Google Scholar 

  • Bender, L., Faretra, G., and Cobrinik, L. LSD and UML treatment of hospitalized disturbed children. In J. Wortis (Ed.), Recent advances in biological psychiatry, New York: Plenum Press, 1963.

    Google Scholar 

  • Bender, L., and Keeler, W. R. The body image of schizophrenic children following electroshock therapy. American Journal of Orthopsychiatry, 1952, 22, 335–355.

    Article  PubMed  Google Scholar 

  • Bender, L., and Nichtern, S. Chemotherapy in child psychiatry. New York State Journal of Medicine, 1956, 56, 2791–2795.

    PubMed  Google Scholar 

  • Boullin, D. J., Coleman, M., and O’Brien, R. A. Abnormalities in platelet 5-hydroxytryp-tamine efflux in patients with infantile autism. Nature, 1970, 226, 371–372.

    Article  PubMed  Google Scholar 

  • Boullin, D. J., Coleman, M., O’Brien, R. A., and Rimland, B. Laboratory predictions of infantile autism based on 5-HT efflux from platelets and their correlation with the Rimland E-2 score. Journal of Autism and Childhood Schizophrenia, 1971, 1, 63–71.

    Article  PubMed  Google Scholar 

  • Bradley, C. The behavior of children receiving benzedrine. American Journal of Psychiatry, 1937, 94, 577–585.

    Google Scholar 

  • Bradley, C., and Bowen, M. Amphetamine (Benzedrine) therapy of children’s behavior disorders. American Journal of Orthopsychiatry, 1941, 11, 92–103.

    Article  Google Scholar 

  • Brambilla, F., and Penati, G. Hormones and behavior in schizophrenia. In D. H. Ford (Ed.), Influence of hormones on the nervous system. Basel: Karger, 1971.

    Google Scholar 

  • Butcher, L. L., Engel, J., and Fuxe, K. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition. Journal of Pharmacy and Pharmacology, 1970, 22, 313–316.

    Article  PubMed  Google Scholar 

  • Burk, H. W., and Menolascino, F. J. Haloperidol in emotionally disturbed mentally retarded individuals. American Journal of Psychiatry, 1968, 124, 1589–1591.

    PubMed  Google Scholar 

  • Campbell, J. D. Manic-depressive disease in children. Journal of the American Medical Association, 1955, 198, 154–157.

    Article  Google Scholar 

  • Campbell, M. A psychotic boy with self-mutilating behavior and the antiaggressive effect of lithium. Paper presented at the 20th Annual Meeting of the American Academy of Child Psychiatry, Washington, D. C., October 18–21, 1973.

    Google Scholar 

  • Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Thiothixene in young disturbed children. A pilot study.Archives of General Psychiatry, 1970, 23, 70–72.

    Article  PubMed  Google Scholar 

  • Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Study of molindone in disturbed preschool children. Current Therapeutic Research, 1971, 13, 28–33. (a).

    PubMed  Google Scholar 

  • Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Imipramine in preschool autistic and schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1971, 1, 267–282. (b).

    Article  PubMed  Google Scholar 

  • Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., and Koh, C. Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 343–358. (a).

    Article  PubMed  Google Scholar 

  • Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., and Koh, C. Lithium-chlorpromazine: A controlled crossover study in hyperactive severely disturbed young children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 234–263. (b).

    Article  PubMed  Google Scholar 

  • Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Acute responses of schizophrenic children to a sedative and “stimulating” neuroleptic: A pharmacologic yardstick. Current Therapeutic Research, 1972, 14, 759–766. (c).

    PubMed  Google Scholar 

  • Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., and Koh, C. Liothyronine treatment in psychotic and nonpsychotic children under six years. Archives of General Psychiatry, 1973, 29, 602–608.

    Article  PubMed  Google Scholar 

  • Campbell, M., Friedman, E., DeVito, E., Greenspan, L., and Collins, P. J. Blood serotonin in disturbed and brain damaged children. Journal of Autism and Childhood Schizophrenia, 1914, 4, 33–41.

    Article  Google Scholar 

  • Campbell, M., Friedman, E., Green, W. H., Collins, P. J., Small, A. M., and Breuer, H. Blood serotonin in schizophrenic children. A preliminary study. International Pharmaco-psychiatry, 1975.

    Google Scholar 

  • Campbell, M., and Hersh, S. P. Observations on the vicissitudes of aggression in two siblings. Journal of Autism and Childhood Schizophrenia, 1971, 1, 398–410.

    Article  PubMed  Google Scholar 

  • Campbell, M., and Shapiro, T. Therapy of psychiatric disorders in childhood. In R. I. Shader (Ed.), Manual of Psychiatric Therapeutics. Boston: Little, Brown and Company, 1975.

    Google Scholar 

  • Campbell, M., Small, A. M., Collins, P. J., Friedman, E., David, R., and Genieser, N. B. Levodopa and levoamphetamine: a crossover study in schizophrenic children. Current Therapeutic Research, 1976, 18.

    Google Scholar 

  • Cerletti, V. Old and new information about electroshock. American Journal of Psychiatry, 1950, 107, 87–94.

    PubMed  Google Scholar 

  • Cleckley, H. M., Sydenstricker, V. P., and Geeslin, L. E. Nicotinic acid in the treatment of atypical psychotic states. Journal of the American Medical Association, 1939, 112, 2107–2110.

    Article  Google Scholar 

  • Coleman, M. Serotonin levels in infant hypothyroidism. Lancet, 1970, 2, 365.

    Article  PubMed  Google Scholar 

  • Coleman, M. Serotonin and central nervous system syndromes in childhood: A review. Journal of Autism and Childhood Schizophrenia, 1973, 3, 27–35.

    Article  PubMed  Google Scholar 

  • Coleman, M., Campbell, M., Freedman, L. S., Roffman, M., Ebstein, R. P., and Goldstein, M. Serum dopamine-B-hydroxylase levels in Down’s syndrome. Clinical Genetics, 1974, 5, 312–315.

    Article  PubMed  Google Scholar 

  • Conners, C. K. Deanol and behavior disorders in children: a critical review of the literature and recommended future studies for determining efficacy. Psychopharmacology Bulletin: Special Issue, Pharmacotherapy of Children, 1973, 188-195.

    Google Scholar 

  • Corson, S. A., Corson, E. O’L., Kirilcuk, V., Knopp, W., and Arnold, L. E. Differential interaction of amphetamines and psychosocial factors in the modification of violent and hyperkinetic behavior and learning disability. Federal Proceedings, 1972, 31, 820.

    Google Scholar 

  • Crane, G. E. Clinical psychopharmacology in its 20th year. Science, 1973, 181, 124–128.

    Article  PubMed  Google Scholar 

  • Creak, M. Schizophrenic syndrome in childhood. Progress report of a working party. Cerebral Palsy Bulletin 1961, 3, 501–504.

    Google Scholar 

  • Danziger, L. Thyroid therapy of schizophrenia. Diseases of the Nervous System, 1958, 19, 373–378.

    PubMed  Google Scholar 

  • Danziger, L., and Kindwall, J. A. Thyroid therapy in some mental disorders. Diseases of the Nervous System, 1953, 14, 3–13.

    PubMed  Google Scholar 

  • DiMascio, A., Soltys, J. J., and Shader, R. I. Psychotropic drug side effects in children. In R. I. Shader, and A. DiMascio (Eds.), Psychotropic Drug Side Effects, Baltimore: Williams & Wilkins Company, 1970, 235–260.

    Google Scholar 

  • Dostal, T. Antiaggressive effect of lithium salts in mentally retarded adolescents. In A. L. Annell (Ed.), Depressive states in childhood and adolescence. Stockhohn: Almquist & Wiksell, 1972.

    Google Scholar 

  • Durell, J., Libow, L. S., Kellam, S. G., and Shader, R. I. Interrelationships between regulation of thyroid gland function and psychosis. Association for Research in Nervous and Mental Diseases, 1963, 43, 387–399.

    Google Scholar 

  • Dutton, G. The growth pattern of psychotic boys. British Journal of Psychiatry, 1964, 110, 101–103.

    Article  PubMed  Google Scholar 

  • Dyson, W. L., and Barcai, A. Treatment of children of lithium responding parents. Current Therapeutic Research, 1970, 12, 286–290.

    PubMed  Google Scholar 

  • Eayrs, J. T. Developmental relationships between brain and thyroid. In R. P. Michael (Ed.), Endocrinology and human behavior. Oxford University Press, 1968.

    Google Scholar 

  • Effron, A. S., and Freedman, A. M. The treatment of behavior disorders in children with benadryl. Journal of Pediatrics, 1953, 42, 261–266.

    Article  PubMed  Google Scholar 

  • Eisenberg, L. The course of childhood schizophrenia. Archives of Neurology and Psychiatry, 1957, 78, 69–83.

    PubMed  Google Scholar 

  • Eisenberg, L. Role of drugs in treating disturbed children. Children, 1964, 2, 167–173.

    Google Scholar 

  • Eisenberg, L. The classification of childhood psychosis reconsidered. Journal of Autism and Childhood Schizophrenia, 1972, 2, 338–342.

    Article  PubMed  Google Scholar 

  • Eisenberg, L., and Conners, C. K. Psychopharmacology in childhood. In N. B. Talbot, J. Kagan, and L. Eisenberg (Eds.), Behavioral Science in Pediatric Medicine. Philadelphia: W. B. Saunders Company, 1971, 397–423.

    Google Scholar 

  • Engelhardt, D. M., Polizos, P., and Margolis, R. A. The drug treatment of childhood psychosis. In W. L. Smith (Ed.), Drugs, development and cerebral function, Springfield, Ill.: Charles C. Thomas, 1972.

    Google Scholar 

  • Engelhardt, D. M., Polizos, P., Waizer, J., and Hoffman, S. P. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1973, 3, 128–137.

    Article  PubMed  Google Scholar 

  • Everett, G. M., and Borcherding, J. W. L-dopa: Effect on concentrations of dopamine, norepinephrine and serotonin in brains of mice. Science, 1970, 168, 849–850.

    Article  PubMed  Google Scholar 

  • Feldmesser-Reiss, E. E. The application of triiodothyronine in the treatment of mental disorders. Journal of Nervous and Mental Disease, 1958, 127, 540–545.

    Article  PubMed  Google Scholar 

  • Fish, B. Drug therapy in child psychiatry: Pharmacological aspects. Comprehensive Psychiatry, 1960, 1, 212–227.

    Article  PubMed  Google Scholar 

  • Fish, B. The influence of maturation and abnormal development on the responses of disturbed children to drugs. Proceedings of the Third World Congress of Psychiatry, 1963.

    Google Scholar 

  • Fish, B. Drug use in psychiatric disorders in children. American Journal of Psychiatry, 1968, 124, 31–36.

    PubMed  Google Scholar 

  • Fish, B. Methodology in child psychopharmacology. In D. H. Efron, J. O. Cole, J. Levine, and J. R. Wittenborn (Eds.), Psychopharmacology, Review of Progress (Public Health Service Publication No. 1836). Washington, D.C.: United States Government Printing Office, 1968.

    Google Scholar 

  • Fish, B. Psychopharmacologic responses of chronic schizophrenic adults as predictors of responses in young schizophrenic children. Psychopharmacology Bulletin, 1970, 6, 12–15.

    Google Scholar 

  • Fish, B. The “one child, one drug” myth of stimulants in hyperkinesis. Importance of diagnostic categories in evaluating treatment. Archives of General Psychiatry, 1971, 25, 193–203.

    Article  Google Scholar 

  • Fish, B., Campbell, M., Shaprio, T., and Floyd, A., Jr. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: The value of less sedative antipsychotic agents. Current Therapeutic Research, 1969, 11, 589–595. (a).

    PubMed  Google Scholar 

  • Fish, B., Campbell, M., Shapiro, T., and Floyd, A., Jr. Schizophrenic children treated with methysergide (Sansert). Diseases of the Nervous System, 1969, 30, 534–540. (b).

    PubMed  Google Scholar 

  • Fish, B., Campbell, M., Shapiro, T., and Weinstein, J. Preliminary findings on thiothixene compared to other drugs in psychotic children under five years. In H. E. Lehmann and T. A. Ban (Eds.), The thioxanthenes: Modern problems of pharmacopsychiatry (Vol. 2). Basel, Switzerland: S. Karger, 1969. (c).

    Google Scholar 

  • Fish, B., Shapiro, T., and Campbell, M. Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluoperazine. American Journal of Psychiatry, 1966, 123, 32–39.

    PubMed  Google Scholar 

  • Fox, W., Gobble, I. F., Clos, M., and Denison, E. A clinical comparison of trifluperidol, haloperidol and chlorpromazine. Current Therapeutic Research, 1964, 6, 409–415.

    PubMed  Google Scholar 

  • Freedman, A. M., Ebin, E. V., and Wilson, E. A. Autistic schizophrenic children. An experiment in the use of D-lysergic acid diethylamide (LSD-25). Archives of General Psychiatry, 1962, 6, 203–213.

    Article  PubMed  Google Scholar 

  • Freeman, R. D. Drug effects on learning in children. A selective review of the past thirty years. Journal of Special Education 1966, 1, 17–43.

    Article  Google Scholar 

  • Freeman, R. D. Psychopharmacology and the retarded child. In F. Menolascino (Ed.), Psychiatric Approaches to Mental Retardation in Childhood. New York: Basic Books, 1970.

    Google Scholar 

  • Freeman, W. Psychosurgery. In S. Arieti (Ed.), American handbook of psychiatry (Vol. II). New York: Basic Books, 1959.

    Google Scholar 

  • Frommer, E. Depressive illness in childhood. In A. Coppen and A. Walk (Eds.), Recent developments in affective disorders. A symposium, British Journal of Psychiatry, 1968, Special Publication No. 2, 117-136.

    Google Scholar 

  • Gallant, D. M., and Bishop, M. P. Molindone: A controlled evaluation in chronic schizophrenic patients. Current Therapeutic Research, 1968, 10, 441–447.

    PubMed  Google Scholar 

  • Gallant, D. M., Bishop, M. P., Nesselhoff, W., Jr., and Sprehe, D. J. Further observations on trifluperidol: A butyrophenone derivative. Psychopharmacologia, 1965, 7, 37–43.

    Article  PubMed  Google Scholar 

  • Gallant, D. M., Bishop, M. P., and Shelton, W. A preliminary evaluation of P-4657B: A thioxanthene derivative. American Journal of Psychiatry, 1966, 123, 345–346.

    PubMed  Google Scholar 

  • Gallant, D. M., Bishop, M. P., Timmons, E., and Gould, A. R. Thiothixene (P-4657B): A controlled evaluation in chronic schizophrenic patients. Current Therapeutic Research, 1966, 8, 153–158.

    PubMed  Google Scholar 

  • Gershon, S., Holmberg, G., Mattson, E., and Marshall, A. Imipramine hydrochloride. Its effects on clinical, autonomic and psychological functions. Archives of General Psychiatry, 1962, 6, 96–101.

    Article  PubMed  Google Scholar 

  • Gjessing, R. Beiträge zur Kenntniss der Pathophysiologie des katatonen Stupors. Archive für Psychiatrie und Nervenkrankheiten, 1932, 96, 319–392.

    Article  Google Scholar 

  • Gjessing, R. Disturbances of somatic functions in catatonia with a periodic course, and their compensation. Journal of Mental Science, 1938, 84, 608–621.

    Google Scholar 

  • Gjessing, R. Beiträge zur Somatologie der periodischen Katatonie. Archive für Psychiatrie und Zeitschrift Neurologic 1953, 191, 191–326.

    Article  Google Scholar 

  • Goldfarb, W. Childhood Schizophrenia. Cambridge, Mass.: Harvard University Press, 1961.

    Google Scholar 

  • Goodwin, F. K., Murphy, D. L., Brodie, H. K. H., and Bunney, W. E. L-dopa, catecholamines, and behavior: A clinical and biochemical study in depressed patients. Biological Psychiatry, 1970, 3, 341–366.

    Google Scholar 

  • Gram, L. F., and Rafaelsen, O. J. Lithium treatment of psychotic children and adolescents. A controlled clinical trial. Acta Psychiatrica Scandinavica, 1972, 48, 253–260.

    Article  PubMed  Google Scholar 

  • Greenbaum, G. H. An evaluation of niacinamide in the treatment of childhood schizophrenia, American Journal of Psychiatry, 1970, 127, 129–132.

    Google Scholar 

  • Gurewitz, S., and Helme, W. H. Effects of electroconvulsive therapy on personality and intellectual functioning of the schizophrenic child. Journal of Nervous and Mental Disease, 1954, 120, 213–226.

    Google Scholar 

  • Hartlage, L. C. Effects of chlorpromazine on learning. Psychological Bulletin, 1965, 64, 235–245.

    Article  PubMed  Google Scholar 

  • Helper, M., Wilcott, R. C., and Garfield, S. L. Effects of chlorpromazine on learning and related processes in emotionally disturbed children. Journal of Consulting Psychology, 1963, 27, 1–9.

    Article  Google Scholar 

  • Heuyer, G., Lang, J. L., and Rivaille, C. J. Aspects cliniques des schizophrenies traitees par l’insuline. Revue de Neuropsychiatrie Infantile et d’Hygiene Mentale de l’Enfance, 1956, 4, 390–396.

    Google Scholar 

  • Himwich, H. E., Kety, S. S., & Smythies, J. R. Amines and schizophrenia. New York: Pergamon Press, 1967.

    Google Scholar 

  • Hoffer, A. Childhood schizophrenia: A case treated with nicotinic acid and nicotinamide. Schizophrenia, 1970, 2, 43–53.

    Google Scholar 

  • Hoffer, A. Mechanisms of action of nicotonic acid and nicotinamide in the treatment of schizophrenia. In D. Hawkins and L. Pauling (Eds.), Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.

    Google Scholar 

  • Hoskins, R. G. The biology of Schizophrenia. New York: Norton & Co., 1946.

    Google Scholar 

  • Kanner, L. Autistic disturbances of affective contact. Nervous child, 1943, 2, 217–250.

    Google Scholar 

  • Kety, S. S. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia. Seminars in Psychiatry, 1972, 4, 233–238.

    PubMed  Google Scholar 

  • Klein, D., and Fink, M. Psychiatric reaction to imipramine. American Journal of Psychiatry, 1962, 119, 432–438.

    PubMed  Google Scholar 

  • Kraft, I. A., Ardali, C., Duffy, J. H., Hart, J. T., and Pearce, P. A clinical study of chlordiazepoxide used in psychiatric disorders of children. International Journal of Neuropsychiatry, 1965, 1, 433–437.

    PubMed  Google Scholar 

  • Krantz, J. C., Jr., Truitt, E. B., Jr., Speers, L., and Ling, A. S. O. New pharmacoconvulsive agent. Science, 1957, 126, 353.

    Article  PubMed  Google Scholar 

  • Kurtis, L. B. Clinical study of the response to nortriptyline on autistic children. International Journal of Neuropsychiatry, 1966, 2, 298–301.

    PubMed  Google Scholar 

  • Lapin, I. P., and Oxenkrug, G. F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet, 1969, 1, 132–136.

    Article  PubMed  Google Scholar 

  • LaVeck, G. D., and Buckley, P. The use of psychopharmacologic agents in retarded children with behavior disorders. Journal of Chronic Diseases, 1961, 13, 174–183.

    Article  PubMed  Google Scholar 

  • LeVann, L. J. Chlordiazepoxide, a tranquilizer with anticonvulsant properties. Canadian Medical Association Journal, 1962, 86, 123–126.

    Google Scholar 

  • LeVann, L. J. Haloperidol in the treatment of behavioral disorders in children and adolescents. Canadian Psychiatric Association Journal, 1969, 14, 217–220.

    Google Scholar 

  • Lipman, R. S. Methodology of drug studies in children. Annual Meeting of the American Orthopsychiatric Association, Chicago, Illinois, March 21, 1968.

    Google Scholar 

  • Lipman, R. S. The use of psychopharmacological agents in residential facilities for the retarded. In Frank J. Menolascino (Ed.), Psychiatric Approaches to Mental Retardation. New York: Basic Books, Inc., 1970, Chapter 15.

    Google Scholar 

  • Lipton, M. A., Ban, T. A., Kane, F. J., Levine, J., Mosher, L. R., and Wittenborn, R. Megavitamin and orthomolecular therapy in psychiatry. Washington, D.C.: American Psychiatric Association, 1973.

    Google Scholar 

  • Loranger, A. W., Goodell, H., Lee, J. H., and McDowell, F. Levo-dopa treatment of Parkinson’s syndrome. Improved intellectual functioning. Archives of General Psychiatry, 1972, 26, 163–168.

    Article  PubMed  Google Scholar 

  • Martini, L., and Ganong, W. F. Frontiers in neuroendocrinology, 1971. London: Oxford University Press, 1971.

    Google Scholar 

  • McAndrew, J. B., Case, A., and Treffert, D. A. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 75–91.

    Article  PubMed  Google Scholar 

  • McCann, S. Mechanism of action of hypothalamic-hypophyseal stimulating and inhibiting hormones. In L. Martini and W. F. Ganong (Eds.), Frontiers in neuroendocrinology. London: Oxford University Press, 1971.

    Google Scholar 

  • McGrath, S. D., O’Brien, P. F., Power, P. J., and Shea, J. R. Nicotinamide treatment of schizophrenia. Report of a multihospital controlled trial. Schizophrenia Bulletin, 1972, 5, 74–76.

    Google Scholar 

  • Moniz, E. Tentative operatoires dans le traitement de certaines psychoses. Paris: Masson et Cie, 1936.

    Google Scholar 

  • Mosher, L. R. Nicotinic acid side effects and toxicity. A review. American Journal of Psychiatry, 1970, 126, 1290–1296.

    PubMed  Google Scholar 

  • Murphy, D. L. Amine precursors, amines and false neurotransmitters in depressed patients. American Journal of Psychiatry, 1972, 129, 141–148. (a).

    PubMed  Google Scholar 

  • Murphy, D. L. L-dopa, behavioral activation and psychopathology. In I. J. Kopin (Ed.), Neurotransmitters. Baltimore: Williams & Wilkins, 1972. (b).

    Google Scholar 

  • Ng, K. Y., Chase, T. N., Colburn, R. W., and Kopin, K. J. L-dopa-induced release of cerebralmonoamines. Science, 1970, 170, 76–77.

    Article  PubMed  Google Scholar 

  • O’Brien, C. P., DiGiacomo, J. N., Fahn, S., and Schwarz, G. A. Mental effects of high-dosage levodopa. Archives of General Psychiatry, 1971, 24, 61–64.

    Article  PubMed  Google Scholar 

  • Oettinger, L. Chlorprothixene in the management of problem children. Diseases of the Nervous System, 1962, 23, 1–4.

    Google Scholar 

  • Osmond, H., and Hoffer, A. Massive niacin treatment in schizophrenia. Review of a nine-year study. Lancet, 1962, 1, 316–319.

    Article  PubMed  Google Scholar 

  • Osmond, H. The background to the niacin treatment. In D. Hawkins and L. Pauling (Eds.), Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.

    Google Scholar 

  • Pauling, L. Orthomolecular psychiatry. Science, 1968, 160, 265–271.

    Article  PubMed  Google Scholar 

  • Persky, H., Zuckerman, M., and Curtis, G. C. Endocrine functions in emotionally disturbed and normal men. Journal of Nervous and Mental Disease, 1968, 146, 488–497.

    Article  PubMed  Google Scholar 

  • Piggott, L. R., and Gottlieb, J. S. Childhood schizophrenia-what is it? Journal of Autism and Childhood Schizophrenia, 1973, 3, 96–105.

    Article  PubMed  Google Scholar 

  • Pilkington, T. L. Comparative effects of librium and taractan on behavior disorders of mentally retarded children. Diseases of the Nervous System, 1961, 22, 573–575. (a).

    PubMed  Google Scholar 

  • Pilkington, T. L. The effects of librium and taractan on the behavior of psychotically disturbed mentally retarded children. Psychopharmacology Abstracts, 1961, 61, 575. (b).

    Google Scholar 

  • Polizos, P., Engelhardt, D. M., Hoffman, S. P., and Waizer, J. Neurological consequences of psychotropic drug withdrawal in schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1973, 3, 247–253.

    Article  PubMed  Google Scholar 

  • Pollack, M., Klein, D. F., Willner, A., Blumberg, A., and Fink, M. Imipramine-induced behavioral disorganization in schizophrenic patients: Physiological and psychological correlates. In J. Wortis (Ed.), Recent advances in biological psychiatry. New York: Plenum Press, 1965.

    Google Scholar 

  • Prange, A. J., Jr., Wilson, I. C., Rabon, A. M., and Lipton, M. A. Enhancement of imipramine antidepressant activity by thyroid hormone. American Journal of Psychiatry, 1969, 126, 457–469.

    PubMed  Google Scholar 

  • Prange, A. J., Jr., and Lipton, M. A. Hormones and behavior: Some principles and findings. In R. I. Shader (Ed.), Psychiatric complications of medical drugs. New York: Raven Press, 1972.

    Google Scholar 

  • Ramsey, R. A., Ban, T. A., Lehmann, H. E., Saxena, B. M., and Bennett, J. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. Canadian Medical Association Journal, 1970, 102, 939–942.

    Google Scholar 

  • Reiss, M. Correlations between changes in mental states and thyroid activity after different forms of treatment. Journal of Mental Sciences, 1954, 100, 687–703.

    Google Scholar 

  • Reiss, M. (Ed.) Psychoendocrinology. New York: Grune & Stratton, 1958.

    Google Scholar 

  • Reiss, M. Clinical and basic neuroendocrine investigations in some states of mental retardation. In D. H. Ford (Ed.), Influence on hormones on the nervous system. Basel: Karger, 1971.

    Google Scholar 

  • Rimland, B. Infantile Autism. New York: Appleton-Century-Crofts, 1964.

    Google Scholar 

  • Rimland, B. High-dosage levels of certain vitamins in the treatment of children with severe mental disorders. In D. Hawkins and L. Pauling (Eds.), Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.

    Google Scholar 

  • Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R., and Howard, C. Effects of L-dopa in autism. Journal of Autism and Childhood Schizophrenia, 1971, 1, 190–205.

    Article  PubMed  Google Scholar 

  • Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., and Plotkin, S. Increased blood serotonin and platelets in early infantile autism. Archives of General Psychiatry, 1970, 23, 566–572.

    Article  PubMed  Google Scholar 

  • Rolo, A., Krinsky, L., Abramson, H., and Goldfarb, L. Preliminary method study of LSD with children. International journal of Neuropsychiatry, 1965, 1, 552–555.

    PubMed  Google Scholar 

  • Ruttenberg, B. A., and Steg, N. Vulnerability and risk-a continuum of etiology in the clinical syndrome of infantile autism. Paper presented at 51st Annual Meeting of the American Orthopsychiatric Association, Workshop 53, San Francisco, California, April 8-12, 1974.

    Google Scholar 

  • Rutter, M. Childhood schizophrenia reconsidered. Journal of Autism and Childhood Schizophrenia, 1972, 2, 315–337.

    Article  PubMed  Google Scholar 

  • Sachar, E. J. Psychoendocrine aspects of acute schizophrenic reactions. Psychosomatic Medicine, 1963, 25, 510–537.

    PubMed  Google Scholar 

  • Sachar, E. J., Harmatz, J., Bergen, H., and Cohler, J. Corticosteroid responses to milieu therapy of chronic schizophrenics. Archives of General Psychiatry, 1966, 15, 310–319.

    Article  PubMed  Google Scholar 

  • Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., and Gallagher, T. F. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Archives of General Psychiatry, 1973, 28, 19–24.

    Article  PubMed  Google Scholar 

  • Safer, D. J., and Allen, R. P. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics, 1973, 51, 660–667.

    PubMed  Google Scholar 

  • Sakel, M. The pharmacological shock treatment of schizophrenia. New York: Nervous and Mental Diseases Publishing Co., 1938.

    Google Scholar 

  • Schain, R. J., and Freedman, D. X. Studies of 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 1961, 58, 315–320.

    Article  PubMed  Google Scholar 

  • Schapiro, S. Influence of hormones and environmental stimulation of brain development. In D. H. Ford (Ed.), Influence of hormones on the nervous system. Basel: S. Karger, 1971.

    Google Scholar 

  • Schaub, C. L., Soulairac, A., and Franchimont, P. Action of chlorpromazine on the hypothalamo-somato-tropic and the hypotholamo-corticotropic axis in man. In D. H. Ford (Ed.), Influence of Hormones on the Nervous System. Basel: Karger, 1971. Pp. 121–139.

    Google Scholar 

  • Schildkraut, J. J., and Kety, S. S. Biogenic amines and emotion. Pharmacological studies suggest a relationship between brain biogenic amines and affective state. Science, 1967, 156, 21–30.

    Article  PubMed  Google Scholar 

  • Schou, M. Lithium in psychiatric therapy and prophylaxis. A review with special regard to its use in children. In A. L. Annell (Ed.), Depressive states in childhood and adolescence. Stockholm: Almquist & Wiksell, 1972.

    Google Scholar 

  • Sheard, M. H. Behavioral effects of p-chlorophenylalanine in rats: Inhibition by lithium. Communications in Behavioral Biology, 1970, 5, 71–73. (a).

    Google Scholar 

  • Sheard, M. H. Effect of lithium on foot shock aggression in rats. Nature, 1970, 228, 284–285. (b).

    Article  PubMed  Google Scholar 

  • Sheard, M. The effect of lithium on behavior. Communications in Contemporary Psychiatry, 1971, 1, 1–6. (a).

    Google Scholar 

  • Sheard, M. H. Effect of lithium on human aggression. Nature, 1971, 230, 113–114. (b).

    Article  PubMed  Google Scholar 

  • Sherman, L., Kim, S., Benjamin, F. and Kolodny, H. D. Effect of chlorpromazine on serum growth-hormone concentration in man. New England Journal of Medicine, 1971, 284, 72–74.

    Article  PubMed  Google Scholar 

  • Sherwin, A. C., Flach, F. F., and Stokes, P. E. Treatment of psychoses in childhood with triiodothyronine. American Journal of Psychiatry, 1958, 115, 166–167.

    PubMed  Google Scholar 

  • Silver, A. A. Management of children with schizophrenia. American Journal of Psychotherapy, 1955, 9, 196–215.

    PubMed  Google Scholar 

  • Simeon, J., Saletu, B., Saletu, M., Itil, T. M. and DaSilva, J. Thiothixene in childhood psychoses. Paper presented at the Third International Symposium on Phenothiazines, Rockville, Maryland, 1973.

    Google Scholar 

  • Simmons, J. Q., III, Leiken, S. J., Lovaas, O. I., Schaeffer, B., and Perloff, B. Modification of autistic behavior with LSD-25. American Journal of Psychiatry, 1966, 122, 1201–1211.

    PubMed  Google Scholar 

  • Simon, G. B., and Gillies, S. M. Some physical characteristics of a group of psychotic children. British Journal of Psychiatry, 1964, 110, 104.

    Article  PubMed  Google Scholar 

  • Simpson, G. M., Cranswick, E. H., and Blair, J. H. Thyroid indices in chronic schizophrenia. Journal of Nervous and Mental Disease, 1963, 137, 582–590.

    Article  PubMed  Google Scholar 

  • Simpson, G. M., Cranswick, E. H., and Blair, J. H. Thyroid indices in chronic schizophrenia. II. Journal of Nervous and Mental Disease, 1964, 138, 581–585.

    Article  PubMed  Google Scholar 

  • Simpson, G. M., and Igbal, J. A preliminary study of thiothixene in chronic schizophrenics. Current Therapeutic Research, 1965, 7, 310–314.

    Google Scholar 

  • Simpson, G. M., and Krakov, L. A preliminary study of molindone (EN-1733A) in chronic schizophrenia. Current Therapeutic Research, 1968, 10, 41–46.

    Google Scholar 

  • Skynner, A. C. R. Effect of chlordiazepoxide. Lancet, 1961, 1, 1110.

    Article  Google Scholar 

  • Snyder, S. H., Taylor, K. M., Coyle, J. T., and Meyerhoff, J. L. The role of brain dopamine in behavioral regulation and the actions of psycho tropic drugs. American Journal of Psychiatry, 1970, 127, 199–207.

    PubMed  Google Scholar 

  • Sokoloff, L., and Roberts, P. Biochemical mechanism of the action of thyroid hormones in nervous and other tissues. In D. H. Ford (Ed.), Influence of hormones on the nervous system. Basel: Karger, 1971.

    Google Scholar 

  • Sprague, R. L., and Werry, J. S. Methodology of psychopharmacological studies with the retarded. In N. R. Ellis (Ed.), International Review of Research in Mental Retardation (Vol. 5). New York: Academic Press, 1971. Pp. 147–219.

    Google Scholar 

  • Sugerman, A. A., and Herrmann, J. Molindone: An indole derivative with anti-psychotic activity. Clinical Pharmacology and Therapeutics, 1967, 8, 261–265.

    PubMed  Google Scholar 

  • Sugerman, A. A., Stolberg, H., and Hermann, J. A pilot study of P-4657B in chronic schizophrenics. Current Therapeutic Research, 1965, 7, 310–314.

    PubMed  Google Scholar 

  • Taylor, K. M., and Snyder, S. H. Amphetamine: Differentiation by D-and L-isomers of behavior involving brain norepinephrine or dopamine. Science, 1970, 168, 1487–1489.

    Article  PubMed  Google Scholar 

  • Tupin, J. P., and Smith, D. B. The long-term use of lithium in aggressive prisoners. Paper presented at the Meeting of the Early Clinical Drug Evaluation Unit, Psycho-pharmacology Research Branch, NIMH, Catonsville, Maryland, June 1972.

    Google Scholar 

  • Waizer, J., Polizos, P., Hoffman, S. P., Engelhardt, D. M., and Margolis, R. A. A single-blind evaluation of thiothixene with outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 378–386.

    Article  PubMed  Google Scholar 

  • Weischer, M. L. On the antiaggressive effect of lithium. Psychopharmacologia, 1969, 15, 245–254.

    Article  PubMed  Google Scholar 

  • Werry, J. S., Weiss, G., Douglas, V., and Martin, J. Studies on the hyperactive child III: The effect of chlorpromazine upon behavior and learning ability. Journal of American Academy of Child Psychiatry, 1966, 5, 292–312.

    Article  Google Scholar 

  • Whitehead, P. L., and Clark, L. D. Effect of lithium carbonate, placebo and thioridazine on hyperactive children. American Journal of Psychiatry, 1970, 127, 824–825.

    PubMed  Google Scholar 

  • Williams, J. M., and Freeman, W. Evaluation of lobotomy with special reference to children. Association for Research in Nervous and Mental Disease, Proceedings, 1953, 31, 311.

    Google Scholar 

  • Wilson, M. B., Prange, A. J., Jr., McClane, T. K., Rabon, A. M., and Lipton, M. A. Thyroid hormone enhancement of imipramine in nonretarded depressions. New England Journal of Medicine, 1970, 282, 1063–1067.

    Article  PubMed  Google Scholar 

  • Wilson, I. C., Prange, A. J., Jr., and Lara, P. P. T3 alone in depressed adults. Paper presented at the Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1972.

    Google Scholar 

  • Wittenborn, J. R., Weber, E. S. P., and Brown, M. Niacin in the long-term treatment of schizophrenia. Archives of General Psychiatry, 1973, 28, 308–315.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Press, New York

About this chapter

Cite this chapter

Campbell, M. (1976). Biological Interventions in Psychoses of Childhood. In: Schopler, E., Reichler, R.J. (eds) Psychopathology and Child Development. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2187-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-2187-3_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-2189-7

  • Online ISBN: 978-1-4684-2187-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics